HomeCGEN • NASDAQ
add
Compugen Ltd
$1.45
Makalipas ang Oras ng Trabaho:(4.83%)+0.070
$1.52
Sarado: Abr 16, 5:48:53 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.38
Sakop ng araw
$1.38 - $1.48
Sakop ng taon
$1.13 - $2.66
Market cap
129.83M USD
Average na Volume
285.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.47M | -95.60% |
Gastos sa pagpapatakbo | 8.28M | -38.54% |
Net na kita | -6.12M | -162.98% |
Net profit margin | -415.84 | -1,532.45% |
Kita sa bawat share | -0.07 | -163.64% |
EBITDA | -7.36M | -140.66% |
Aktuwal na % ng binabayarang buwis | -0.07% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 103.26M | 103.72% |
Kabuuang asset | 115.00M | -5.22% |
Kabuuang sagutin | 60.08M | 7.72% |
Kabuuang equity | 54.91M | — |
Natitirang share | 93.51M | — |
Presyo para makapag-book | 2.26 | — |
Return on assets | -15.69% | — |
Return on capital | -30.85% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.12M | -162.98% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
Itinatag
Peb 10, 1993
Website
Mga Empleyado
74
